The TWEAK/Fn14 signaling axis has been implicated in tumor growth and metastasis and therapeutic agents that target TWEAK or Fn14 are in development for potential use in cancer patients [1, 2, 16]. This evidence concerns the gene TNFRSF12A and cancer.